Pfizer, Inc. · NYSE:PFE
Pfizer — 42nd Annual J.P. Morgan Healthcare Conference 2024
5 slides from Pfizer's conference presentation, Jan 8, 2024
Slide 1: 42nd Annual J.P. Morgan Healthcare Conference
42nd Annual J.P. Morgan Healthcare Conference January 8, 2024 Breakthroughs 42nd that change Annual J.P. Morgan patients'Conference Healthcare lives ®
Slide 2: Forward-Looking Statements and Non-GAAP Financial Information
Forward-Looking Statements and Non-GAAP Financial Information Our discussions during this conference call will include forward-looking statements that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such sta
Slide 3: 2023: Moving Beyond a Challenging Year
2023: Moving Beyond a Challenging Year A challenging 2023 with missed expectations, yet significant achievements seeding success for 2024 onward 2023 Achievements A Strong Foundation for 2024+ • Treated >600M patients with • Removed many COVID product our medicines and vaccines1 uncertainties • Repo
Slide 4: 2024 Key Priorities
2024 Key Priorities Executing with excellence against our strategic goals • Achieve world-class oncology leadership • Maximize performance of our new products • Deliver next wave of pipeline innovation • Expand margins by realigning our cost base • Allocate capital to enhance shareholder value 42nd
Slide 5: Footnotes
Footnotes (1) The Patients Treated metric is a preliminary forecast for the full year of 2023 based on Pfizer and third-party datasets as of December 2023 and subject to change. This estimate does not include Seagen patients treated. Figures may be limited given the coverage provided by external sou
Pfizer — 42nd Annual J.P. Morgan Healthcare Conference 2024 on 6ix